🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
2.740
-0.145 (-5.03%)
At close: Nov 20, 2026, 4:00 PM EST
2.730
-0.010 (-0.36%)
After-hours: Nov 20, 2026, 7:30 PM EST

Verrica Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
22.8935.587.575.129.0312
Revenue Growth
-25.75%370.22%47.66%-43.27%-24.73%-
Cost of Revenue
13.1712.314.5821.0412.9215.93
Gross Profit
9.7223.28-7.01-15.92-3.89-3.93
Selling, General & Admin
38.8135.2258.8247.3117.4126.98
Research & Development
11.14-----
Operating Expenses
49.9535.2258.8247.3117.4126.98
Operating Income
-40.23-11.94-65.84-63.22-21.3-30.91
Interest Expense
-1.92-7.74-9.41-3.96-2.17-4.3
Interest & Investment Income
0.560.931.422.740.480.12
Other Non Operating Income (Expenses)
1.752.65-2.67-0.01-0.06-
EBT Excluding Unusual Items
-39.84-16.11-76.5-64.46-23.05-35.08
Gain (Loss) on Sale of Assets
-0.25-0.25-0.08-2.54--
Other Unusual Items
-1.53-1.53---1.44-
Pretax Income
-43.32-17.89-76.58-67-24.49-35.08
Earnings From Continuing Operations
--17.89-76.58-67-24.49-35.08
Net Income
-43.32-17.89-76.58-67-24.49-35.08
Net Income to Common
-43.32-17.89-76.58-67-24.49-35.08
Net Income Growth
------
Shares Outstanding (Basic)
20115533
Shares Outstanding (Diluted)
20115533
Shares Change
121.68%105.61%14.26%32.72%26.32%8.20%
EPS (Basic)
-2.22-1.68-14.78-14.78-7.17-12.97
EPS (Diluted)
-2.22-1.68-14.78-14.78-7.17-13.00
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
--17.63-60.95-38.94-18.95-28.47
Free Cash Flow Per Share
--1.66-11.77-8.59-5.55-10.53
Gross Margin
42.46%65.44%-92.70%--43.08%-32.74%
Operating Margin
-175.73%-33.56%-870.16%-1233.84%-235.78%-257.57%
Profit Margin
-189.23%-50.27%-1012.15%-1307.47%-271.11%-292.33%
Free Cash Flow Margin
--49.55%-805.63%-759.93%-209.83%-237.21%
EBITDA
-39.73-11.45-64.88-62.67-20.84-30.66
EBITDA Margin
-173.56%-32.20%---230.76%-255.53%
D&A For EBITDA
0.50.490.960.550.450.24
EBIT
-40.23-11.94-65.84-63.22-21.3-30.91
EBIT Margin
-175.73%-33.56%---235.78%-257.57%
Revenue as Reported
22.8935.587.575.129.03-
SEC Filings: 10-K · 10-Q